Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-09-23

Clinical Trial Update: Improving Function, Quality of Life, Glycemia in Diabetics With Dementia [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating whether improving function, quality of life, and glycemic control in people with diabetes and dementia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nebraska | Conditions: Diabetes Mellitus, Alzheimer's Disease | Phase 4 | Status: WITHDRAWN